Lasar patent opposition analysis

The comprehensive analysis of Lasar opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Lasar

Patent NumberTitleApplicantOpposition DateOpposition Company
Method For Regulating Glycosylation Of Recombinant GlycoproteinLG CHEMMay 5, 2021MAIWALD PATENT UND RECHTSANWALTSGESELLSCHAFT
Human Application Of Engineered Chimeric Antigen Receptor (Car) T-CellsBOARD OF REGENTSMar 24, 2021MAIWALD
Attenuated Viruses Useful For VaccinesTHE RESEARCH FOUNDATION OF THE STATE UNIVERSITY OF NEW YORKMar 13, 2019MAIWALD PATENT UND RECHTSANWALTSGESELLSCHAFT
Methods Of Preventing And Removing Trisulfide BondsBIOGEN MAJan 18, 2019MAIWALD PATENTANWALTS UND RECHTSANWALTSGESELLSCHAFT
Production Of Glycoproteins With Low N-Glycolylneuraminic Acid (Neu5Gc) ContentLEK PHARMACEUTICALS DDOct 24, 2018MAIWALD PATENT UND RECHTSANWALTSGESELLSCHAFT
Method To Improve Virus Removal In Protein PurificationF HOFFMANN LA ROCHEOct 10, 2018MAIWALD PATENTANWALTS UND RECHTSANWALTSGESELLSCHAFT
Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECHAug 1, 2018MAIWALD PATENT UND RECHTSANWALTSGESELLSCHAFT